MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study.

Mitchell JM, Bogenschutz M, Lilienstein A, Harrison C, Kleiman S, Parker-Guilbert K, Ot'alora G M, Garas W, Paleos C, Gorman I, Nicholas C, Mithoefer M, Carlin S, Poulter B, Mithoefer A, Quevedo S, Wells G, Klaire SS, van der Kolk B, Tzarfaty K, Amiaz R, Worthy R, Shannon S, Woolley JD, Marta C, Gelfand Y, Hapke E, Amar S, Wallach Y, Brown R, Hamilton S, Wang JB, Coker A, Matthews R, de Boer A, Yazar-Klosinski B, Emerson A, Doblin R

Open source

DOI
10.1038/s41591-021-01336-3
Published
2021 Jun
Container
Nature medicine
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41591-021-01336-3,
  title = {MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study.},
  author = {Mitchell JM and Bogenschutz M and Lilienstein A and Harrison C and Kleiman S and Parker-Guilbert K and Ot'alora G M and Garas W and Paleos C and Gorman I and Nicholas C and Mithoefer M and Carlin S and Poulter B and Mithoefer A and Quevedo S and Wells G and Klaire SS and van der Kolk B and Tzarfaty K and Amiaz R and Worthy R and Shannon S and Woolley JD and Marta C and Gelfand Y and Hapke E and Amar S and Wallach Y and Brown R and Hamilton S and Wang JB and Coker A and Matthews R and de Boer A and Yazar-Klosinski B and Emerson A and Doblin R},
  year = {2021},
  journal = {Nature medicine},
  doi = {10.1038/s41591-021-01336-3},
  url = {https://doi.org/10.1038/s41591-021-01336-3}
}

RIS

TY  - JOUR
TI  - MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study.
AU  - Mitchell JM
AU  - Bogenschutz M
AU  - Lilienstein A
AU  - Harrison C
AU  - Kleiman S
AU  - Parker-Guilbert K
AU  - Ot'alora G M
AU  - Garas W
AU  - Paleos C
AU  - Gorman I
AU  - Nicholas C
AU  - Mithoefer M
AU  - Carlin S
AU  - Poulter B
AU  - Mithoefer A
AU  - Quevedo S
AU  - Wells G
AU  - Klaire SS
AU  - van der Kolk B
AU  - Tzarfaty K
AU  - Amiaz R
AU  - Worthy R
AU  - Shannon S
AU  - Woolley JD
AU  - Marta C
AU  - Gelfand Y
AU  - Hapke E
AU  - Amar S
AU  - Wallach Y
AU  - Brown R
AU  - Hamilton S
AU  - Wang JB
AU  - Coker A
AU  - Matthews R
AU  - de Boer A
AU  - Yazar-Klosinski B
AU  - Emerson A
AU  - Doblin R
PY  - 2021
JO  - Nature medicine
DO  - 10.1038/s41591-021-01336-3
UR  - https://doi.org/10.1038/s41591-021-01336-3
ER  - 

APA

JM, M., M, B., A, L., C, H., S, K., K, P., M, O. G., W, G., C, P., I, G., C, N., M, M., S, C., B, P., A, M., S, Q., G, W., SS, K., B, V. D. K., K, T., R, A., R, W., S, S., JD, W., C, M., Y, G., E, H., S, A., Y, W., R, B., S, H., JB, W., A, C., R, M., A, D. B., B, Y., A, E., & R, D. (2021). MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study.. Nature medicine. https://doi.org/10.1038/s41591-021-01336-3

Source records